Atoxigen Overview

  • Founded
  • 2009
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 2

Atoxigen General Information


Provider of research and development services intended to evaluate toxicology reports. The company's services include evaluation of the safety and efficacy of substances for human, veterinary and environmental use from the first stages of development to preclinical trials, enabling hospitals and clinics to generate reports on regular, predictive toxicology and efficiency of ingredients and products in skin microbiome and endocrine disruptors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Outcome Management (Healthcare)
Primary Office
  • Hôpital Xavier Arnozan
  • Avenue du Haut-Lévèque
  • 33600 Pessac
  • France
+33 05 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Atoxigen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Grant 01-Jan-2016 $3.26K Completed Generating Revenue
To view Atoxigen’s complete valuation and funding history, request access »

Atoxigen Executive Team (1)

Name Title Board Seat Contact Info
Saadia Berrada Ph.D Founder, Chief Executive Officer & President
To view Atoxigen’s complete executive team members history, request access »

Atoxigen Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
UNESCO Other 000 0000 000000 0
Plateforme Technologique d'Innovation Biomédicale Accelerator/Incubator Minority 000 0000 000000 0
To view Atoxigen’s complete investors history, request access »